These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11992302)

  • 1. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation.
    Muretto P; Angelucci E; Lucarelli G
    Ann Intern Med; 2002 May; 136(9):667-72. PubMed ID: 11992302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summaries for patients. Reversibility of liver scarring in patients who are cured of thalassemia.
    Ann Intern Med; 2002 May; 136(9):I36. PubMed ID: 11992322
    [No Abstract]   [Full Text] [Related]  

  • 3. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
    Angelucci E; Muretto P; Lucarelli G; Ripalti M; Baronciani D; Erer B; Galimberti M; Giardini C; Gaziev D; Polchi P
    Blood; 1997 Aug; 90(3):994-8. PubMed ID: 9242528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.
    Angelucci E; Muretto P; Nicolucci A; Baronciani D; Erer B; Gaziev J; Ripalti M; Sodani P; Tomassoni S; Visani G; Lucarelli G
    Blood; 2002 Jul; 100(1):17-21. PubMed ID: 12070002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
    Wu SF; Peng CT; Wu KH; Tsai CH
    Hemoglobin; 2006; 30(2):215-8. PubMed ID: 16798646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
    Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
    Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation.
    Meo A; Ruggeri A; La Rosa MA; Zanghì L; Morabito N; Duca L
    Hemoglobin; 2006; 30(1):131-7. PubMed ID: 16540426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.
    Olivieri NF; Brittenham GM; McLaren CE; Templeton DM; Cameron RG; McClelland RA; Burt AD; Fleming KA
    N Engl J Med; 1998 Aug; 339(7):417-23. PubMed ID: 9700174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver iron stores before and after bone marrow transplantation for thalassemia.
    Politi P; Lucarelli G; Capriotti L; Salvadori P; Dardanelli C; Barbanti I
    Prog Clin Biol Res; 1989; 309():281-9. PubMed ID: 2675096
    [No Abstract]   [Full Text] [Related]  

  • 11. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia.
    Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Gaziev D; Erer B; La Nasa G; Barbanti I
    Br J Haematol; 1995 Apr; 89(4):868-73. PubMed ID: 7772524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.
    Deugnier Y; Turlin B; Ropert M; Cappellini MD; Porter JB; Giannone V; Zhang Y; Griffel L; Brissot P
    Gastroenterology; 2011 Oct; 141(4):1202-11, 1211.e1-3. PubMed ID: 21741344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
    Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective evaluation of iron chelation therapy in children with severe beta-thalassemia. A six-year study.
    Maurer HS; Lloyd-Still JD; Ingrisano C; Gonzalez-Crussi F; Honig GR
    Am J Dis Child; 1988 Mar; 142(3):287-92. PubMed ID: 3344715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.
    Gumus E; Abbasoglu O; Tanyel C; Gumruk F; Ozen H; Yuce A
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28211259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C virus infection in thalassemia.
    Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
    Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic iron concentration and total body iron stores in thalassemia major.
    Angelucci E; Brittenham GM; McLaren CE; Ripalti M; Baronciani D; Giardini C; Galimberti M; Polchi P; Lucarelli G
    N Engl J Med; 2000 Aug; 343(5):327-31. PubMed ID: 10922422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hepatocellular carcinoma in a thalassemia unit.
    Fragatou S; Tsourveloudis I; Manesis G
    Hemoglobin; 2010 Jun; 34(3):221-6. PubMed ID: 20524812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Maira D; Cassinerio E; Marcon A; Mancarella M; Fraquelli M; Pedrotti P; Cappellini MD
    Ann Hematol; 2017 Nov; 96(11):1931-1936. PubMed ID: 28875336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.